Literature DB >> 31163352

Lack of nsP2-specific nuclear functions attenuates chikungunya virus replication both in vitro and in vivo.

Chetan D Meshram1, Tetyana Lukash1, Aaron T Phillips1, Ivan Akhrymuk1, Elena I Frolova1, Ilya Frolov2.   

Abstract

Chikungunya virus (CHIKV) is an important arthritogenic human pathogen that is already circulating in both hemispheres. In the present study, we substituted VLoop, located on the surface of nsP2, by other amino acid sequences. These modifications had deleterious effects on viral nuclear functions and made CHIKV incapable of interfering with the induction of type I interferon and the antiviral response in both mouse and human cells. Importantly, the identified mutations have no significant effects on the synthesis of virus-specific RNAs and viral structural proteins. The designed mutants induced a few orders of magnitude lower viremia but remained highly immunogenic in mice. Thus, the proposed modifications of nsP2 can additionally improve the safety of the attenuated strain CHIKV 181/25. Furthermore, defined mutations in the macro domain of another nonstructural protein, nsP3, additionally reduce cytopathogenicity of nsP2 mutants in human cells, and can be potentially applied for CHIKV attenuation.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Alphaviruses; Chikungunya virus; Cytopathic effect; Transcription inhibition; Vaccines; Viral RNA replication; Virus-host interaction; nsP2; nsP3

Mesh:

Substances:

Year:  2019        PMID: 31163352      PMCID: PMC7204530          DOI: 10.1016/j.virol.2019.05.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  62 in total

1.  Cleavage between nsP1 and nsP2 initiates the processing pathway of Sindbis virus nonstructural polyprotein P123.

Authors:  Y Shirako; J H Strauss
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

2.  Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

Authors:  R Edelman; C O Tacket; S S Wasserman; S A Bodison; J G Perry; J A Mangiafico
Journal:  Am J Trop Med Hyg       Date:  2000-06       Impact factor: 2.345

Review 3.  Current status of flavivirus vaccines.

Authors:  A D Barrett
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

4.  Mutations in the E2 Glycoprotein and the 3' Untranslated Region Enhance Chikungunya Virus Virulence in Mice.

Authors:  David W Hawman; Kathryn S Carpentier; Julie M Fox; Nicholas A May; Wes Sanders; Stephanie A Montgomery; Nathaniel J Moorman; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

5.  Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells.

Authors:  S Perri; D A Driver; J P Gardner; S Sherrill; B A Belli; T W Dubensky; J M Polo
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 6.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

7.  The 5'UTR-specific mutation in VEEV TC-83 genome has a strong effect on RNA replication and subgenomic RNA synthesis, but not on translation of the encoded proteins.

Authors:  Raghavendran Kulasegaran-Shylini; Varatharasa Thiviyanathan; David G Gorenstein; Ilya Frolov
Journal:  Virology       Date:  2009-03-17       Impact factor: 3.616

8.  Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.

Authors:  R M Kinney; G J Chang; K R Tsuchiya; J M Sneider; J T Roehrig; T M Woodward; D W Trent
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus- and plus-strand RNA synthesis.

Authors:  J A Lemm; T Rümenapf; E G Strauss; J H Strauss; C M Rice
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

10.  IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon.

Authors:  Josephine M Reynaud; Dal Young Kim; Svetlana Atasheva; Aliaksandra Rasalouskaya; James P White; Michael S Diamond; Scott C Weaver; Elena I Frolova; Ilya Frolov
Journal:  PLoS Pathog       Date:  2015-04-30       Impact factor: 6.823

View more
  8 in total

1.  Mutations in Hypervariable Domain of Venezuelan Equine Encephalitis Virus nsP3 Protein Differentially Affect Viral Replication.

Authors:  Chetan D Meshram; Aaron T Phillips; Tetyana Lukash; Nikita Shiliaev; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

2.  Structural and Functional Characterization of Host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.

Authors:  Tetyana Lukash; Tatiana Agback; Francisco Dominguez; Nikita Shiliaev; Chetan Meshram; Elena I Frolova; Peter Agback; Ilya Frolov
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

3.  Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design.

Authors:  Sixue Zhang; Atefeh Garzan; Nicole Haese; Robert Bostwick; Yohanka Martinez-Gzegozewska; Lynn Rasmussen; Daniel N Streblow; Mark T Haise; Ashish K Pathak; Corinne E Augelli-Szafran; Mousheng Wu
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

4.  Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models.

Authors:  Awadalkareem Adam; Huanle Luo; Samantha R Osman; Binbin Wang; Christopher M Roundy; Albert J Auguste; Kenneth S Plante; Bi-Hung Peng; Saravanan Thangamani; Elena I Frolova; Ilya Frolov; Scott C Weaver; Tian Wang
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

5.  Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.

Authors:  Elena I Frolova; Oksana Palchevska; Tetyana Lukash; Francisco Dominguez; William Britt; Ilya Frolov
Journal:  J Virol       Date:  2022-07-25       Impact factor: 6.549

6.  Facile method for delivering chikungunya viral replicons into mosquitoes and mammalian cells.

Authors:  Hui-Chung Lin; Der-Jiang Chiao; Chang-Chi Lin; Szu-Cheng Kuo
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

7.  NAP1L1 and NAP1L4 Binding to Hypervariable Domain of Chikungunya Virus nsP3 Protein Is Bivalent and Requires Phosphorylation.

Authors:  Francisco Dominguez; Nikita Shiliaev; Tetyana Lukash; Peter Agback; Oksana Palchevska; Joseph R Gould; Chetan D Meshram; Peter E Prevelige; Todd J Green; Tatiana Agback; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

8.  Chikungunya virus antagonizes cGAS-STING mediated type-I interferon responses by degrading cGAS.

Authors:  L G Webb; J Veloz; J Pintado-Silva; T Zhu; M V Rangel; T Mutetwa; L Zhang; D Bernal-Rubio; D Figueroa; L Carrau; R Fenutria; U Potla; St P Reid; J S Yount; K A Stapleford; S Aguirre; A Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2020-10-15       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.